Stockreport

Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations [Yahoo! Finance]

Molecular Partners AG - American Depositary Shares  (MOLN) 
PDF biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced that it will issue its fourth quarter and full year fi [Read more]